| Dr Brian H Lee, MD | |
|
612 W Duarte Rd Ste 101, Arcadia, CA 91007-9220 | |
| (626) 447-0035 | |
| Not Available |
| Full Name | Dr Brian H Lee |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 612 W Duarte Rd Ste 101, Arcadia, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225392178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA10283200 (New Jersey) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | A153953 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital Of Southern Ca | Arcadia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beverly Radiology Medical Group Iii | 3476466376 | 242 |
| Arcadia Radiology Medical Group A Professional Corporation | 9537134184 | 13 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20031106000784 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Cedars-sinai Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316984388 PECOS PAC ID: 0941106645 Enrollment ID: O20040202000464 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20040202001145 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Kern Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700821972 PECOS PAC ID: 7214826460 Enrollment ID: O20040315000421 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Diagnostic Radiological Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710931910 PECOS PAC ID: 4981680220 Enrollment ID: O20040626000471 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Arcadia Radiology Medical Group A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841228764 PECOS PAC ID: 9537134184 Enrollment ID: O20040827000915 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Desert Advanced Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568416147 PECOS PAC ID: 6406749613 Enrollment ID: O20050622001415 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Pronet Imaging Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528099488 PECOS PAC ID: 5890722755 Enrollment ID: O20050721000831 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20060221000914 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Stockton Diagnostic Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356538201 PECOS PAC ID: 0749386894 Enrollment ID: O20070507000122 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | San Fernando Valley Interventional Radiology And Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942350889 PECOS PAC ID: 3476651431 Enrollment ID: O20070614000478 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Fresno Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659456499 PECOS PAC ID: 2466553128 Enrollment ID: O20070724000813 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Norcal Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003965997 PECOS PAC ID: 7911099346 Enrollment ID: O20070815000403 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Radnet Medical Imaging - San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548345382 PECOS PAC ID: 9830283761 Enrollment ID: O20070921000636 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Emeryville Advanced Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376597930 PECOS PAC ID: 3375637051 Enrollment ID: O20070926000354 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Modesto Advanced Diagnostic Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133893 PECOS PAC ID: 1850336736 Enrollment ID: O20080313000323 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Entity Name | Santa Rosa Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689890444 PECOS PAC ID: 2567408859 Enrollment ID: O20100324000598 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian H Lee, MD 612 W Duarte Rd Ste 101, Arcadia, CA 91007-9220 Ph: () - | Dr Brian H Lee, MD 612 W Duarte Rd Ste 101, Arcadia, CA 91007-9220 Ph: (626) 447-0035 |
News Archive
A study on macaques by researchers at the National Institute for Physiological Sciences has identified part of the brain that specifically registers when another macaque receives a reward, showing that this affects the subjective value placed on one's own resources and rewards, providing insight into the emotion of envy.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, announced that its most advanced ImmTAC drug, IMCgp100 for the treatment of late stage melanoma, has reached Maximum Tolerated Dose (MTD) and the dose escalation part of this Phase I clinical study has been completed. The company has now initiated a Phase IIa clinical trial in the UK and USA.
Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies, announced today the results of a Phase I renal impairment study with Bendavia.
› Verified 1 days ago
Dr. Juan Carlos Echeverria, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8004 Fax: 626-898-8235 | |
Dr. Shengyang Wu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr Ste 120, Arcadia, CA 91007 Phone: 626-574-3657 Fax: 626-898-8016 | |
Mr. Leon Edward Lis, MD Radiology Medicare: Medicare Enrolled Practice Location: 612 W Duarte Rd, Ste 101, Arcadia, CA 91007 Phone: 626-445-4850 Fax: 626-445-0482 | |
Mr. Wilson Shen Wong, MD Radiology Medicare: Medicare Enrolled Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8610 | |
Thomas Zung, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1630 La Ramada Ave, Arcadia, CA 91006 Phone: 626-447-4477 Fax: 626-355-6962 | |
Mr. Jose Solomon Tandoc, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 612 W Duarte Rd Ste 101, Arcadia Radiology Medical Group, Arcadia, CA 91007 Phone: 626-445-4850 Fax: 626-445-0482 |